Peripheral CB1 cannabinoid receptor blockade improves cardiometabolic risk in mouse models of obesity
Published 2010 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Peripheral CB1 cannabinoid receptor blockade improves cardiometabolic risk in mouse models of obesity
Authors
Keywords
-
Journal
JOURNAL OF CLINICAL INVESTIGATION
Volume 120, Issue 8, Pages 2953-2966
Publisher
American Society for Clinical Investigation
Online
2010-07-27
DOI
10.1172/jci42551
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- CB1 Signaling in Forebrain and Sympathetic Neurons Is a Key Determinant of Endocannabinoid Actions on Energy Balance
- (2010) Carmelo Quarta et al. Cell Metabolism
- CB1 Antagonism Exerts Specific Molecular Effects on Visceral and Subcutaneous Fat and Reverses Liver Steatosis in Diet-Induced Obese Mice
- (2010) T. Jourdan et al. DIABETES
- Rimonabant prevents additional accumulation of visceral and subcutaneous fat during high-fat feeding in dogs
- (2009) Joyce M. Richey et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Conversion of 4-cyanomethyl-pyrazole-3-carboxamides into CB1 antagonists with lowered propensity to pass the blood–brain-barrier
- (2009) Jean-Marie Receveur et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Peripherally acting CB1-receptor antagonist: the relative importance of central and peripheral CB1 receptors in adiposity control
- (2009) M-H Son et al. INTERNATIONAL JOURNAL OF OBESITY
- The Acyclic CB1R Inverse Agonist Taranabant Mediates Weight Loss by Increasing Energy Expenditure and Decreasing Caloric Intake
- (2008) Carol Addy et al. Cell Metabolism
- Cannabinoid Type 1 Receptor Blockade Promotes Mitochondrial Biogenesis Through Endothelial Nitric Oxide Synthase Expression in White Adipocytes
- (2008) L. Tedesco et al. DIABETES
- Peripheral, but Not Central, CB1 Antagonism Provides Food Intake-Independent Metabolic Benefits in Diet-Induced Obese Rats
- (2008) R. Nogueiras et al. DIABETES
- Cannabinoid type 1 receptors in human skeletal muscle cells participate in the negative crosstalk between fat and muscle
- (2008) K. Eckardt et al. DIABETOLOGIA
- Hepatic CB1 receptor is required for development of diet-induced steatosis, dyslipidemia, and insulin and leptin resistance in mice
- (2008) Douglas Osei-Hyiaman et al. JOURNAL OF CLINICAL INVESTIGATION
- Leptin controls adipose tissue lipogenesis via central, STAT3–independent mechanisms
- (2008) Christoph Buettner et al. NATURE MEDICINE
- Overactive endocannabinoid signaling impairs apolipoprotein E-mediated clearance of triglyceride-rich lipoproteins
- (2008) M. A. Ruby et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- HSP72 protects against obesity-induced insulin resistance
- (2008) J. Chung et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cannabinoids inhibit insulin secretion and cytosolic Ca2+ oscillation in islet β-cells via CB1 receptors
- (2007) Masanori Nakata et al. REGULATORY PEPTIDES
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now